羧基疗法市场－全球产业规模、份额、趋势、机会和预测，按类型、应用、最终用户、地区和竞争细分，2020-2030 年

2024 年全球羧酸疗法市场价值为 3,531 万美元，预计到 2030 年将达到 6,994 万美元，预测期内复合年增长率为 12.04%。由于消费者越来越倾向于非侵入性美容手术，认为这种手术能够带来明显的效果并且恢復时间最短，因此市场正在稳步增长。二氧化碳疗法透过控制二氧化碳的注射进行，因其在治疗脂肪团、妊娠纹、黑眼圈和局部脂肪堆积等症状方面的功效而受到广泛关注。它能够改善皮肤弹性、刺激胶原蛋白生成和增强微循环，这增加了其在美容和医疗领域的吸引力。

消费者对自然效果的需求，以及美感意识和可支配收入的提高，正在推动市场扩张。透过社群媒体和名人潮流所宣传的美丽理念的影响尤其影响着年轻族群。设备设计的技术发展提高了安全性、精确度和舒适度，从而促进了更广泛的临床应用。此外，羧基疗法正越来越多地与微针疗法、中胚层疗法和雷射疗法一起被纳入综合美容治疗中。它的应用范围也正在扩大，包括伤口癒合和脱髮等医学适应症，这扩大了其在皮肤病学和治疗护理环境中的相关性。

关键市场驱动因素

非侵入性美容手术的需求不断增长

主要市场挑战

认知有限和监管限制

主要市场趋势

便携式和家用设备的普及率不断上升

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球羧基疗法市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（桌上型、便携式、其他）
  • 按应用（美容医学、皮肤科、妇科、血管科、骨科和风湿病科、运动医学、其他）
  • 按最终使用者（医院、美容诊所、健康中心）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美羧基疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲羧基疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区羧基疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美羧基疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲羧基疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• DTA Medical
• Fosun Pharmaceutical Co., Ltd.
• Merz Pharma GmbH & Co. KGaA
• Cosmo Pro Ltd.
• Allergan plc
• Carbossiterapia Italiana
• Beijing Jontelaser Technologies Co. Ltd.
• Kastner-Praxisbedarf
• Mezopharma
• Alvi Prague

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Carboxy Therapy Market was valued at USD 35.31 Million in 2024 and is projected to reach USD 69.94 Million by 2030, expanding at a CAGR of 12.04% during the forecast period. The market is growing steadily, driven by rising consumer preference for non-invasive cosmetic procedures that offer visible results with minimal recovery time. Carboxy therapy-administered through the controlled infusion of carbon dioxide-has gained traction for its efficacy in treating conditions such as cellulite, stretch marks, under-eye circles, and localized fat deposits. Its ability to improve skin elasticity, stimulate collagen production, and enhance microcirculation has increased its appeal across aesthetic and medical segments.

Consumer demand for natural-looking results, along with increased aesthetic awareness and disposable income, is fueling market expansion. The influence of beauty ideals promoted via social media and celebrity trends is particularly impacting younger demographics. Technological developments in device design-enabling enhanced safety, precision, and comfort-are encouraging broader clinical adoption. Furthermore, carboxy therapy is being increasingly incorporated into comprehensive aesthetic treatments alongside microneedling, mesotherapy, and laser therapies. Its application is also widening to include medical indications such as wound healing and alopecia, which is expanding its relevance in dermatological and therapeutic care settings.

Key Market Drivers

Rising Demand for Non-Invasive Aesthetic Procedures

The growing preference for minimally invasive cosmetic treatments is a key factor propelling the carboxy therapy market. As patients seek procedures with fewer risks, faster recovery, and natural outcomes, carboxy therapy aligns with these expectations by offering aesthetic enhancements without surgical intervention. The technique is especially effective for facial rejuvenation, body contouring, and skin tightening. According to the American Society of Plastic Surgeons, minimally invasive procedures increased by 7% in 2023, outpacing surgical ones. With rising demand for treatments such as neuromodulators, dermal fillers, and chemical peels, carboxy therapy is gaining attention as a complementary or alternative solution.

Key Market Challenges

Limited Awareness and Regulatory Constraints

One of the main challenges facing the market is the lack of widespread awareness among patients and healthcare providers in certain regions, especially in developing countries where aesthetic medicine is still evolving. Additionally, inconsistent regulations regarding device usage and practitioner certification can lead to varied treatment outcomes and patient safety concerns. The absence of standardization, along with potential side effects like bruising and discomfort, may deter first-time users. Furthermore, high equipment costs and ongoing consumable expenses create financial barriers for smaller clinics, limiting broader market adoption.

Key Market Trends

Rising Adoption of Portable and Home-Use Devices

The growing popularity of portable and home-use carboxy therapy devices is a notable market trend. Consumers are increasingly seeking convenience-driven skincare solutions that offer flexibility and privacy. Compact, easy-to-use devices equipped with pre-set treatment modes and digital CO2 control features are enabling at-home treatments, particularly among younger, tech-savvy users. These portable systems are reshaping the way individuals manage beauty regimens, offering cost-effective alternatives to clinic visits while still delivering noticeable results. This trend is expanding the reach of carboxy therapy beyond professional settings into the consumer wellness market.

Key Market Players

• DTA Medical
• Fosun Pharmaceutical Co., Ltd.
• Merz Pharma GmbH & Co. KGaA
• Cosmo Pro Ltd.
• Allergan plc
• Carbossiterapia Italiana
• Beijing Jontelaser Technologies Co. Ltd.
• Kastner-Praxisbedarf
• Mezopharma
• Alvi Prague

Report Scope:

In this report, the Global Carboxy Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Carboxy Therapy Market, By Type:

• Tabletop
• Portable
• Others

Carboxy Therapy Market, By Application:

• Aesthetic Medicine
• Dermatology
• Gynaecology
• Angiology
• Orthopaedic & Rheumatology
• Sports Medicine
• Others

Carboxy Therapy Market, By End User:

• Hospitals
• Aesthetic Clinics
• Wellness Centers

Carboxy Therapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Carboxy Therapy Market.

Available Customizations:

Global Carboxy Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Carboxy Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Tabletop, Portable, Others)
  • 5.2.2. By Application (Aesthetic Medicine, Dermatology, Gynaecology, Angiology, Orthopaedic & Rheumatology, Sports Medicine, Others)
  • 5.2.3. By End User (Hospitals, Aesthetic Clinics, Wellness Centers)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Carboxy Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Carboxy Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Carboxy Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Carboxy Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Carboxy Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Carboxy Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Carboxy Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Carboxy Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Carboxy Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Carboxy Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Carboxy Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Carboxy Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Carboxy Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Carboxy Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Carboxy Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Carboxy Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Carboxy Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Carboxy Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Carboxy Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Carboxy Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Carboxy Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Carboxy Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Carboxy Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Carboxy Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. DTA Medical
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Fosun Pharmaceutical Co., Ltd.
• 14.3. Merz Pharma GmbH & Co. KGaA
• 14.4. Cosmo Pro Ltd.
• 14.5. Allergan plc
• 14.6. Carbossiterapia Italiana
• 14.7. Beijing Jontelaser Technologies Co. Ltd.
• 14.8. Kastner-Praxisbedarf
• 14.9. Mezopharma
• 14.10. Alvi Prague

15. Strategic Recommendations

16. About Us & Disclaimer